Inhibition of eEF2K Synergizes with Glutaminase Inhibitors or 4EBP1 Depletion to Suppress Growth of Triple-Negative Breast Cancer Cells

0
7
Researchers showed that genetic or pharmacological inhibition of eukaryotic elongation factor-2 kinase (eEF2K) cooperated with glutamine starvation, and synergized with glutaminase inhibitors to suppress growth of diverse TNBC cell lines.
[Scientific Reports]
Ju, Y., Ben-David, Y., Rotin, D., & Zacksenhaus, E. (2021). Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells. Scientific Reports, 11(1), 9181. https://doi.org/10.1038/s41598-021-88816-1 Cite
Full Article